|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
2U54CA163071-06
|
$1,427,230
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers
|
5R01CA184968-04
|
$509,161
|
SIKIC, BRANIMIR
|
STANFORD UNIVERSITY
|
|
(PQD5) Avatar-directed Treatment for Ovarian Cancer
|
5R01CA184502-04
|
$714,297
|
WEROHA, SARAVUT
|
MAYO CLINIC ROCHESTER
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
2U54CA163068-06
|
$1,656,304
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
402 -- CHEMOPREVENTION OF COLORECTAL CANCER . CONTRACTOR: UNIVERSITY OF OKLAHOMA, HEALTH SCIENCES CENTER, DUNS: 878648294. CONTRACT NO: HHSN261500038I, TASK ORDER HHSN26100011. FROM 9/15/17 TO 9/14/
|
261201500038I
|
$1,236,052
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
2U01CA164974-07
|
$2,195,369
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-06
|
$639,740
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Multimodal Imaging Strategy for Preclinical Optimization of Anticancer Nanomedicines
|
5F31CA203476-02
|
$34,742
|
RADFORD, DAVID
|
UNIVERSITY OF UTAH
|
|
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
|
5R01CA175318-03
|
$354,563
|
HATEFI, ARASH
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
A network platform to connect drug response and prognosis phenotypes for cancers
|
5R01CA196631-02
|
$395,911
|
LI, HU
|
MAYO CLINIC ROCHESTER
|
|
A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery
|
1R03CA216127-01
|
$77,000
|
YANG, YANG
|
YALE UNIVERSITY
|
|
A Novel Agent for Ovarian Cancer
|
1R43CA221477-01
|
$300,000
|
XIE, GANG
|
MEDICON, INC.
|
|
A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer
|
5R00CA166228-05
|
$249,000
|
GATZA, MICHAEL
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy
|
5R44CA206606-02
|
$1,004,186
|
WINRAM, SCOTT
|
CYNVEC, LLC
|
|
A Systems Biology Approach to Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
|
1F30CA213737-01
|
$44,244
|
MCGEHEE, CORDELIA
|
MAYO CLINIC ROCHESTER
|
|
A Target-Directed Reagent Pipeline via Microfluidic mRNA Display
|
1R21CA204708-01A1
|
$227,675
|
MALMSTADT, NOAH
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$256,560
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
Activating Cell Death Pathways in Breast Cancer Cells
|
ZIA SC 007263
|
$524,596
|
Lipkowitz, Stanley
|
CCR (NCI)
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
5U24CA180921-05
|
$705,863
|
BECICH, MICHAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Algorithms for Literature-Guided Multi-Platform Identification of Cancer Subtypes
|
5R21CA209848-02
|
$162,581
|
CHUNG, DONGJUN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Ambient dioxin exposure and cancer risk in women (IWHS and AHS)
|
ZIA CP010125-10712
|
$56,170
|
Jones, Rena
|
DCEG (NCI)
|
|
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
|
5R01CA182832-04
|
$323,044
|
MATEI, DANIELA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
An in vivo model for CCNE1 amplified tumorigenesis
|
1F32CA221093-01
|
$60,990
|
KROEGER, PAUL
|
UNIVERSITY OF PENNSYLVANIA
|
|
Analysis of BRCA Testing Patterns Using the Utah Population Database
|
1R03CA212911-01
|
$75,834
|
KOHLMANN, WENDY
|
UNIVERSITY OF UTAH
|
|
Analysis of BRCA1 Recombination Functions
|
5R01CA095175-13
|
$328,700
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
|
5R01CA181543-04
|
$395,654
|
BRUGGE, JOAN
|
HARVARD MEDICAL SCHOOL
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca
|
5R01CA172667-05
|
$334,984
|
NOMURA, DANIEL
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$2,592,300
|
Berzofsky, Jay
|
CCR (NCI)
|
|
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
|
3R01CA135354-07S1
|
$99,082
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
|
5R01CA135354-07
|
$380,000
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Assessment of Screening Modalities for Gynecologic Cancers
|
ZIA CP010126-10495
|
$126
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute
|
5R50CA211108-02
|
$250,131
|
MINDERMAN, HANS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Averting recurrent and resistant ovarian tumors
|
1R01CA211175-01
|
$454,502
|
WANG, QIEN
|
OHIO STATE UNIVERSITY
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,497,944
|
Custer, Mary
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
BCDDP: Breast cancer detection demonstration project followup study - I
|
ZIA CP010182-01030
|
$41,204
|
Schairer, Catherine
|
DCEG (NCI)
|
|
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance
|
5R01CA193249-02
|
$621,318
|
LUTGENDORF, SUSAN
|
UNIVERSITY OF IOWA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biomedical Applications of Expanded Porphyrins: Development of Gold-Texaphyrin Conjugates
|
2R01CA068682-25
|
$360,416
|
SESSLER, JONATHAN
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
Blocking NK cell shedding of CD16a to increase cancer cell killing
|
5R01CA203348-02
|
$444,991
|
WALCHECK, BRUCE
|
UNIVERSITY OF MINNESOTA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|